MEDi Robot for Pain Management at Induction

Cognitive Therapy Clinical Trial

Official title:

Efficacy of a Preparation Intervention for the Management of Children's Pain and Fear During Induction: Help From a Robot Named MEDi

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02859051
• Other study ID #: REB16-0148
• Status: Completed
• Phase: N/A
• Start date: July 8, 2016
• Est. completion date: May 25, 2018

Study information

• Verified date: April 2021
• Source: University of Calgary
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine if a preparation teaching intervention before IV insertion, taught by MEDi to children and their parents, will lead to lower levels of expected and experienced pain and fear and less distressing pain memories, as compared to children who receive standard care. In addition, it will be examined whether this preparation intervention will lead to greater parental self-efficacy, less anxiety, and less distressing pain memories as compared to controls.

Description:

The primary aim is to determine the impact of using a humanoid robot in comparison to standard care. This proposal describes the first study in the world to test such novel technology for preparation teaching intervention before IV insertion. This work builds on previous research conducted by the research team and represents a logical next step for this collaborative group. This project team includes established and emerging leaders in pain management research. This will ensure successful implementation and completion of the project. These methods of teaching preparation have the potential for widespread application to other medical procedures and clinical settings (eg. oncology dentistry) and lead to improved health outcomes for children by easing their suffering and improving the quality of their healthcare encounters.

1.2 Research Questions

Research Question 1.) Does preparation administered by a humanoid robot (MEDi) reduce expectancies and experience of pain and fear of IV insertion in children?

Hypothesis 1.) Children who receive preparation by MEDi will report expecting and experiencing lower levels of fear and pain at IV insertion as compared to youth receiving standard care.

Research Question 2.) Does preparation administered by MEDi lead to higher self-efficacy and lower anxiety in parents of children undergoing IV insertion?

Hypothesis 2.) Parents of children who receive preparation by MEDi will report higher levels of self-efficacy and lower anxiety at their children's IV insertion as compared to youth receiving standard care.

Research Question 3.) Do children who receive preparation administered by MEDi and their parents have more accurate and positively estimated memories of pain and fear as compared to youth receiving standard care and their parents?

Hypothesis 3.) Children who receive preparation administered by MEDi and their parents will report more accurate and positively estimated memories of pain and fear as compared to youth receiving standard care and their parents.

Research Question 4.) Do children who receive preparation administered by MEDi prior to IV insertion and their parents expect to experience less pain, fear, anxiety, and higher self-efficacy in pain coping at future needle procedures as compared to youth receiving standard care and their parents?

Hypothesis 4.) Children who receive preparation administered by MEDi prior to IV insertion and their parents will report expecting to experience lower pain, fear, and anxiety and higher self-efficacy in pain coping at future needle procedures as compared to youth receiving standard care and their parents.

2.1 Study Design & Setting

This study is a single-centre prospective randomized, controlled, two-armed trial: (1) humanoid robot, MEDi, provides preparation for intravenous placement; and (2) standard care. Patients will be recruited from day surgery at the Alberta Children's Hospital Calgary, AB. This study will follow the high methodological standards for reporting RCTs according to the Consolidated Standards of Reporting Trials guidelines - extension for nonpharmacological treatments and this trial will be registered with clinicaltrials.gov.

2.2. Study Population

Legal guardians and/or patients with the ability to understand the study will be asked to provide written informed consent prior to participation. Day surgery patients, between the ages of 4-12 years old who are presenting for general surgery under general anesthesia, and in the American Society of Anesthesiologists class 1 or 2, will be included.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 137
• Est. completion date: May 25, 2018
• Est. primary completion date: May 25, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 4 Years to 12 Years

Eligibility

Inclusion Criteria:

• presenting for general surgery under general anesthesia, and in the American Society of Anesthesiologists class 1 or 2

Exclusion Criteria:

• patient presenting for day surgery

• patient requires an intravenous placed in day surgery unit

• patient cognitively unable to self-report pain

• patient with a hearing or visual impairment or developmental disability that precludes self-reporting ability

• family or child that is unable to communicate in English

• previous allergic reaction to propofol or lidocaine

Related Conditions & MeSH terms

• Cognitive Therapy

Intervention

Device:
• Humanoid Robot MEDi
Humanoid robot programmed with cognitive-behavioral interventions such as role modeling, teaching coping strategies, positive reinforcement, parent encouragement

Locations

Country	Name	City	State
Canada	Alberta Children's Hospital	Calgary	Alberta

Sponsors (2)

Lead Sponsor	Collaborator
University of Calgary	Alberta Health Services

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	child's pain	Faces Pain Scale-Revised (FPS-R) (Hicks, 2001)	at moment of child's IV start
Secondary	child's fear	Children's Fear Scale (McMurtry, Noel, Chambers, & McGrath, 2011)	at the moment of OR entry
Secondary	parent self-efficacy	use 0-10 numerical rating scales to report the degree to which they feel self-efficacy in their ability to help their child manage their pain and fear	30 mins to 3 hours before induction
Secondary	parent anxiety	Parents will be asked to report on their own level of anxiety during the needle procedure using a 0-10 NRS ranging from 0 ('not at all nervous or anxious') to 10 ('most nervous or anxious').	30 mins to 3 hours before induction
Secondary	children's memory	, parents and children will be asked to provide their free recall of each of those periods using open-ended prompts	2 weeks after child's induction
Secondary	parents' memory	, parents and children will be asked to provide their free recall of each of those periods using open-ended prompts	2 weeks after child's induction